List of Treatments for Breast Cancer

Nerlynx (Neratinib)

Overview
Nerlynx is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as adjuvant (post-surgery) treatment for adults with early stage breast cancer in which HER2 is overexpressed or amplified.… read more

Neulasta (Pegfilgrastim)

Overview

Neulasta is a prescription drug approved by the Food and Drug Administration (FDA) to lower the risk of developing infections after receiving chemotherapy or some types of radiation. Neulasta is also known by… read more

Neupogen (Filgrastim)

Overview
Neupogen is a prescription drug approved by the Food and Drug Administration (FDA) to help prevent febrile neutropenia (a lack of white blood cells, plus fever). If your white blood cell count is low due to… read more

Ogivri (Trastuzumab-dkst)

Overview
Ogivri is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat breast cancer in cases where tumors overexpress the HER2 protein. Ogivri is also known by its drug name,… read more

Ontruzant (Trastuzumab-Dttb)

Overview
Ontruzant is approved by the U.S. Food and Drug Administration (FDA) for HER2-overexpressing breast cancer. Ontruzant is prescribed for both early-stage and metastatic HER2-positive breast cancer. Individuals are…

Orserdu (Elacestrant)

Overview
Orserdu is approved by the U.S. Food and Drug Administration (FDA) for treating postmenopausal women and adult men with estrogen receptor-positive (ER-positive), HER2-negative, ESR1-mutated advanced, or…

Perjeta (Pertuzumab)

Overview
Perjeta is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer in cases where tumors overexpress the HER2 protein and chemotherapy or anti-HER2 therapy… read more

Pertuzumab

Overview
Pertuzumab is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer in cases where tumors overexpress the HER2 protein and chemotherapy or anti-HER2… read more

Phesgo (Pertuzumab, trastuzumab, and hyaluronidase-zzxf)

Overview
Phesgo is a combination prescription drug approved by the U.S. Food and Drug Administration (FDA) for use with chemotherapy to treat adults with early-stage HER-2 positive breast cancer. Phesgo is also approved… read more

Piqray (Alpelisib)

Overview

Piqray is a prescription medication approved by the Food and Drug Administration (FDA) to treat advanced or metastatic breast cancer in postmenopausal women. Piqray is also known by its drug name, Alpelisib.… read more

Radiation Therapy

Overview
Radiation therapy helps prevent the return or spread of cancer. It is most frequently used after surgery, especially lumpectomy. If you have had a mastectomy, your doctor may decide that you don’t need… read more

Reconstructive Surgery

Overview
Many women choose reconstructive surgery after a mastectomy or bilateral mastectomy in order to restore the appearance and feel of their breasts. There are many different options for reconstruction, including… read more

Sentinel node biopsy

Overview
Sentinel node biopsy is the surgical removal of one or more lymph nodes for testing. It is a diagnostic procedure performed in order to determine whether breast cancer has developed the ability to spread… read more

Soltamox (Tamoxifen Citrate)

Overview
Soltamox is approved by the U.S. Food and Drug Administration (FDA) for the treatment of estrogen receptor (ER)-positive metastatic breast cancer, as an adjuvant treatment for early-stage ER-positive breast…

Talzenna (Talazoparib)

Overview
Talzenna is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with HER2-negative and germline BRCA-mutated breast cancer that is metastatic or locally advanced.… read more

Tamoxifen

Overview
Tamoxifen is a prescription drug first approved by the U.S. Food and Drug Administration (FDA) in 1977 to treat breast cancer. Tamoxifen was later also approved to prevent breast cancer. Tamoxifen is commonly… read more

Taxotere (Docetaxel)

Overview
Taxotere is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat locally advanced or metastatic breast cancer after chemotherapy hasn’t worked. Taxotere is also approved to treat… read more

Tecentriq (Atezolizumab)

Overview
Tecentriq is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with triple-negative breast cancer (TNBC) in cases where surgery is not an option and the tumor is… read more

Trastuzumab

Overview
Trastuzumab is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer in cases where tumors overexpress the HER2 protein and one or more chemotherapy… read more

Trazimera (Trastuzumab-Qyyp)

Overview
Trazimera is approved by the U.S. Food and Drug Administration (FDA) for the treatment of HER2-overexpressing breast cancer. Individuals who are eligible for Trazimera must have breast cancer that overexpresses…

Trodelvy (Sacituzumab govitecan-hziy)

Overview
Trodelvy is a combination prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with metastatic triple-negative breast cancer who have tried at least two other treatments.… read more

Truqap (Capivasertib)

Overview
Truqap is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in combination with fulvestrant to treat some cases of hormone receptor (HR)-positive, human epidermal growth factor… read more

Tukysa (Tucatinib)

Overview
Tukysa is a prescription drug approved by the Food and Drug Administration (FDA) to treat adults with advanced inoperable or metastatic HER2+ breast cancer. Tukysa may be also referred to by its drug name,… read more

Tykerb (Lapatinib)

Overview
Tykerb is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer in combination with capecitabine in cases where tumors overexpress the HER2 protein. The… read more

Verzenio (Abemaciclib)

Overview
Verzenio is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat advanced or metastatic breast cancer. Verzenio may be prescribed in combination with Faslodex (fulvestrant), or… read more

Xeloda (Capecitabine)

Overview
Xeloda is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer. Xeloda may be prescribed either as monotherapy (on its own) in cases resistant to… read more

Zarxio (Filgrastim-sndz)

Overview
Zarxio is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat febrile neutropenia (a lack of white blood cells, plus fever). If you have neutropenia caused by chemotherapy for… read more

Zoladex (Goserelin Implant)

Overview
Zoladex is approved by the U.S. Food and Drug Administration (FDA) for the palliative treatment of advanced breast cancer in premenopausal and perimenopausal women, according to the prescribing information. This…